The equine breeding industry continues to be somewhat inefficient, even with existing technology. On average, foaling rates are low when compared with that of other livestock. One major contributor is the inability to accurately predict ovulation in mares, which ovulate before the end of estrus, leaving much variability in coordinating insemination. A more efficient, less invasive method that could replace or reduce the need for constant teasing and ultrasonography to evaluate follicular activity is needed. In both dairy cattle and women, a change in body temperature has been shown to occur immediately prior to ovulation. Research on horses has been limited, although one study reported no useable relationship between body temperature and ovulation in mares (Ammons, 1989). The current study utilized thirty-eight mature cycling American Quarter Horse mares, and was conducted from March-August 2004. Each mare was implanted in the nuchal ligament with a microchip that can be used for identification purposes, but is also capable of reporting body temperature. Once an ovulatory follicle (>35mm) was detected using ultrasonography and the mare was exhibiting signs of estrus, the mare's follicle size and temperature were recorded approximately every six hours until ovulation. Not only was the temperature collected using the microchips, but the corresponding rectal temperature was also recorded using a digital thermometer. A significant effect (p<0.05) on body temperature was noted in relation to the presence or absence of an ovulatory follicle (>35mm) under different circumstances. When evaluating the rectal temperatures, no significant difference was found in temperature in relation to the presence or absence of a follicle. However, in the temperatures obtained using the microchip, temperature was higher (p<0.05) with the presence of a follicle of greater than 35mm. This may be due to the extreme sensitivity of the microchip implant and its ability to more closely reflect minute changes in body temperature.

Centrifugation of stallion semen is an integral part of the cryopreservation procedure, primarily allowing for the concentration of sperm and removal of seminal plasma. In addition, centrifugation is required for maximizing spermatozoal quality in semen from some stallions subjected to cooled transport, because of the detrimental effects of long-term exposure to high levels of seminal plasma. The centrifugation process, however, has potential deleterious effects, including reduction in sperm quality as well as loss of sperm numbers. Since centrifugation plays such a crucial role in semen processing, two experiments were designed to evaluate more efficient centrifugation methods to meet the demands of the equine industry. In Experiment 1, semen was centrifuged in two different tube types (nipple- or conical-bottom), using a cushioned technique (Eqcellsire® Component B) with two different extenders (opaque-INRA96 or clear-HGLL). For Experiment 2, nipple-tube centrifugation was conducted at two different g forces (400 or 600) for 20 min, using three different iodixanol cushion media, Eqcellsire® Component B, OptiPrep[TM], or Cushion Fluid[TM]. Regardless of tube or extender types, centrifugation of semen resulted in sperm recovery rates ≥90%; however, centrifugation in INRA 96 extender yielded higher sperm motility values than did centrifugation in HGLL extender (P < 0.05). Cushion type or g force did not impact post-centrifugation semen quality, based on the laboratory values measured (P > 0.05). These results indicate that cushioned centrifugation of stallion semen in either conical-bottom or nipple-bottom tubes can yield a high sperm harvest, while maintaining sperm function. An optically opaque extender, as is typically used in the equine breeding industry, can be used to achieve this goal. The fertility rate (94%; 131/140) following cushioned semen centrifugation in a commercial program this past year indicates that these laboratory results are transferable to the clinical setting.

Centrifugation of stallion semen is an integral part of the cryopreservation procedure, primarily allowing for the concentration of sperm and removal of seminal plasma. In addition, centrifugation is required for maximizing spermatozoal quality in semen from some stallions subjected to cooled transport, because of the detrimental effects of long-term exposure to high levels of seminal plasma. The centrifugation process, however, has potential deleterious effects, including reduction in sperm quality as well as loss of sperm numbers. Since centrifugation plays such a crucial role in semen processing, two experiments were designed to evaluate more efficient centrifugation methods to meet the demands of the equine industry. In Experiment 1, semen was centrifuged in two different tube types (nipple- or conical-bottom), using a cushioned technique (Eqcellsire® Component B) with two different extenders (opaque-INRA96 or clear-HGLL). For Experiment 2, nipple-tube centrifugation was conducted at two different g forces (400 or 600) for 20 min, using three different iodixanol cushion media, Eqcellsire® Component B, OptiPrep™, or Cushion Fluid™. Regardless of tube or extender types, centrifugation of semen resulted in sperm recovery rates ≥ 90%; however, centrifugation in INRA 96 extender yielded higher sperm motility values than did centrifugation in HGLL extender (P < 0.05). Cushion type or g force did not impact post-centrifugation semen quality, based on the laboratory values measured (P > 0.05). These results indicate that cushioned centrifugation of stallion semen in either conical-bottom or nipple-bottom tubes can yield a high sperm harvest, while maintaining sperm function. An optically opaque extender, as is typically used in the equine breeding industry, can be used to achieve this goal. The fertility rate (94%; 131/140) following cushioned semen centrifugation in a commercial program this past year indicates that these laboratory results are transferable to the clinical setting.

Syftet med studien var att explorativt undersöka vilken betydelse hästen har för brittiska soldater och veteraner som varit ute i krig och återvänt med någon form av ohälsa. Studiens frågeställningar var: Hur används hästen på Horseback UK  som en del i tillfrisknandet för brittiska soldater och veteraner som varit ute i krig? Hur beskriver brittiska soldater och veteraner som varit ute i krig hästens betydelse för livskvalitén? För att besvara frågeställningarna tillämpades en metod som bestod av kvalitativa intervjuer. Intervjuerna utfördes på Horseback UK i Skottland som är en välgörenhetsorganisation, skapad för att ge en trygg och säker miljö. De arbetar med hjälp av hästar för att hjälpa de som tjänstgör eller tjänstgjort i den brittiska armén och kommit tillbaka med någon form fysisk eller psykisk ohälsa. Undersökningsgruppen bestod av sju individer, fem var soldater eller veteraner och två var grundarna till organisationen. Resultatet av denna studie visar att samtliga soldater och veteraner var överens om att deras livskvalité har förbättrats efter att hästen kom in i deras liv och att den har haft en viktig betydelse för dem. Exakt hur hästen påverkar just livskvalitén går dock inte att förklara.

Centrifugation of stallion semen is an integral part of the cryopreservation procedure, primarily allowing for the concentration of sperm and removal of seminal plasma. In addition, centrifugation is required for maximizing spermatozoal quality in semen from some stallions subjected to cooled transport, because of the detrimental effects of long-term exposure to high levels of seminal plasma. The centrifugation process, however, has potential deleterious effects, including reduction in sperm quality as well as loss of sperm numbers. Since centrifugation plays such a crucial role in semen processing, two experiments were designed to evaluate more efficient centrifugation methods to meet the demands of the equine industry. In Experiment 1, semen was centrifuged in two different tube types (nipple- or conical-bottom), using a cushioned technique (Eqcellsire® Component B) with two different extenders (opaque-INRA96 or clear-HGLL). For Experiment 2, nipple-tube centrifugation was conducted at two different g forces (400 or 600) for 20 min, using three different iodixanol cushion media, Eqcellsire® Component B, OptiPrep™, or Cushion Fluid™. Regardless of tube or extender types, centrifugation of semen resulted in sperm recovery rates ≥ 90%; however, centrifugation in INRA 96 extender yielded higher sperm motility values than did centrifugation in HGLL extender (P < 0.05). Cushion type or g force did not impact post-centrifugation semen quality, based on the laboratory values measured (P > 0.05). These results indicate that cushioned centrifugation of stallion semen in either conical-bottom or nipple-bottom tubes can yield a high sperm harvest, while maintaining sperm function. An optically opaque extender, as is typically used in the equine breeding industry, can be used to achieve this goal. The fertility rate (94%; 131/140) following cushioned semen centrifugation in a commercial program this past year indicates that these laboratory results are transferable to the clinical setting.

Equine laminitis is a debilitating disease that causes extreme sufferring in afflicted horses and often results in a lifetime of chronic pain. The exact sequence of pathophysiological events culminating in laminitis has not yet been characterized, and this is reflected in the lack of any consistently effective therapeutic strategy. For these reasons, we used a newly developed 21,000 element equine-specific whole-genome oligoarray to perform transcriptomic analysis on laminar tissue from horses with experimentally induced models of laminitis: carbohydrate overload (CHO), hyperinsulinaemia (HI), and oligofructose (OF). Samples were collected during the developmental (DEV) and Obel grade 1 (OG1) stages of laminitis for the CHO model. For the HI model, samples were collected at the Obel grade 2 (OG2) stage. For the OF model, samples were collected at the 12 h and 24 h time points. Appropriate control samples were obtained for all models. This is the first genome-wide transcriptome analysis of laminar tissue using an equine 21,000 70-mer long oligoarray approach in CHO, HI and OF induced laminitis. Overall, we identified the differential expression of genes encoding S100 calcium binding proteins, extracellular matrix proteins, glycoproteins, transporters, olfactory receptors, genes involved in signal transduction, body‟s homeostasis, apoptosis, and immune response. Between CHO and OF models of laminitis, there were more shared genes. We discovered several common differentially expressed genes (i.e., ADAMTS1, CYCS and CXCL14) among all three models that are likely important to the pathogenesis of equine laminitis. We also discovered what appear to be central roles of apoptosis, inflammatory response, and intracellular ion homeostasis molecular processes in CHO and OF models of laminitis. Pathway analysis detected the NOD-like receptor signaling pathway, which is involved in recognition of intracellular bacteria in both the CHO and OF models of laminitis. Genetic network analysis indicated convergent pathway core molecules present in equine acute laminitis: p38 MAPK and NF-κB. Most importantly, our results of overexpression of anti-microbial genes (i.e., DEFB4, PI3, and CXCL14) suggest the central involvement of these genes in the progression of early equine laminitis and will allow refinement of current hypotheses of disease pathogenesis.

Rhodococcus equi causes severe pneumonia, resulting in disease and sometimes death of foals. Infection is thought to occur by inhalation of dust contaminated with virulent R equi. A recent study of 3 horse breeding farms in Ireland found airborne concentrations of virulent R equi to be significantly higher in stables than in paddocks. More importantly, another study from Australia established an association of airborne concentrations of virulent R equi with the prevalence of R equi pneumonia at 28 farms. The extent to which these associations extend to other farms in different parts of the world is not known. Two farms in central Kentucky with recurrent R equi pneumonia in foals were studied from February through July 2008. Air samples were collected and environmental factors were measured hourly for a 24-hour period each month from stalls and paddocks used to house mares and their foals at each farm. In 2009, samples were collected from 47 foals from stalls at a single horse-breeding farm in central Kentucky on days 1-2, days 7-9, and days 14-16 of life. Concentrations of airborne virulent R equi were determined via a modified colony immunoblot technique. Airborne concentrations of virulent R equi were significantly higher (P = 0.016) from 6:00 A.M. through 11:59 P.M. than for the period from midnight through 5:59 A.M. Presence of the mare and foal at the time of sampling was significantly (P < 0.001) associated with increased airborne concentrations of virulent R equi in stalls. The presence of virulent R equi in stalls was significantly (P = 0.045) more likely at 7 days of age for foals subsequently found to be affected by rhodococcal pneumonia. These findings suggest that recovery of airborne virulent R equi is less likely between 12:00 A.M. and 5:59 A.M., relative to other times, that airborne concentrations of virulent R equi are significantly increased when horses are present at the site for collection of air samples, and that environments containing airborne virulent R equi during the first week of life may influence the risk of subsequent disease for a foal.

Equine infectious anemia virus (EIAV) causes rapid development of acute disease followed by recurring episodes of fever, thrombocytopenia and viremia, termed chronic EIA. Most infected horses control the virus by immune mechanisms and become inapparent carriers. To further our understanding of the equine immune response to EIAV, a multi-probe ribonuclease protection assay (RPA) was developed to quantitate equine-specific cytokine mRNAs. Eleven template plasmids specific to ten equine cytokine genes and the ?-actin gene were generated, from which radiolabeled anti-sense RNA probes were produced. The RPA simultaneously quantitated mRNA levels of interleukin (IL)-1, IL-1, IL-6, IL-8, IL-10, IL-12 p35, IL-12 p40, interferon (IFN)-, transforming growth factor (TGF)-1 and tumor necrosis factor (TNF)- in equine peripheral blood mononuclear cells and equine monocyte-derived macrophages (EMDM). The assay detected as few as 5105 RNA molecules and displayed coefficients of variation of 0.03-0.08 when normalized to -actin expression. Using this RPA, cytokine expression in EMDM infected with 2 molecularly cloned viruses (EIAV17 and EIAV19) was determined. EIAV17 varies from EIAV19 only in env, rev and LTR and causes fatal disease in Shetland ponies. When added to EMDM cultures, virulent EIAV17 stimulated expression of IL-1, IL-1, IL-6, IL-10 and TNF-. These cytokine mRNAs were significantly elevated by 0.5 to 1 hr post infection (hpi) and returned to basal levels by 12 to 24 hpi, indicating modulation by early event(s), such as receptor binding. In contrast to EIAV17, EIAV19 is avirulent in vivo and failed to induce any of the tested cytokines in EMDM. These data show a direct correlation between the virulence of the EIAV clone and the induction of cytokines. The cytokines stimulated by EIAV17 may contribute to EIA-associated symptoms, enhance viral replication in the host, and regulate the host immune response. To determine whether cytokine induction requires EIAV17 replication, EMDM cultures were exposed to UV-inactivated EIAV17 and cytokine induction was monitored. UV-inactivation did not block cytokine induction by EIAV17, suggesting dispensability of viral replication. Given that EIAV17 induces cytokines in a rapid and replication-independent manner, the activation of cytokine expression is likely mediated by binding of EIAV17 to equine macrophage receptor(s).

Objectives were to determine if low-dose, continuous infusion of GnRH from Fall to Spring, would prevent seasonal anovulation in mares. Twenty Quarter Horse mares, ages 18 mo to 24 yrs, were stratified by age and body condition score and assigned randomly to either a saline control (n = 9) or GnRH (n = 11) treatment group. Treatments were instituted between September 23 and October 9, 2002. Gonadotropinreleasing hormone was delivered in 0.9% physiological saline via Alzet osmotic minipumps (Model 2004) placed sc at the base of the neck, with Silastic sham pumps placed in control mares. Pumps were inserted on day 3 following ovulation or during the follicular phase if ovulation had not occurred. Delivery rate of GnRH was 2.5 ug/h (60 ug/d) for the first 60 d, followed by 5.0 ug/h (120 ug/d) thereafter, with all pumps replaced every 30 d. By December 1, all mares had become anovulatory and remained anovulatory until February. Mean serum concentrations of LH were not affected by treatment in anovulatory mares. In contrast, control mares that exhibited ovulatory cycles after treatment onset had higher (P < 0.05) mean concentrations of LH during all phases of the estrous cycle except diestrus. Mean serum concentrations of FSH were not affected by treatment, but were lower (P < 0.05) from November though January relative to all other months in anovulatory mares. Interovulatory intervals in mares that cycled temporarily did not differ between groups. Ovulatory control mares had slightly larger (P < 0.10) follicles overall than GnRH-treated mares; however, ovulatory follicle diameters for control and GnRH-treated mares did not differ. Ovulatory control mares had higher (P < 0.10) mean concentrations of progesterone during metestrus and late diestrus. In a subgroup of control (n =5) and GnRH-treated (n = 5) mares, total releasable pools of LH in response to 1 mg GnRH did not differ between groups. Ovulation resumed in 3 control and 3 GnRH-treated mares by March 30. Results indicate that continuous infusion of native GnRH at the doses employed herein is not sufficient to maintain ovulatory cycles during the anovulatory season.

The equine breeding industry continues to be somewhat inefficient, even with existing technology. On average, foaling rates are low when compared with that of other livestock. One major contributor is the inability to accurately predict ovulation in mares, which ovulate before the end of estrus, leaving much variability in coordinating insemination. A more efficient, less invasive method that could replace or reduce the need for constant teasing and ultrasonography to evaluate follicular activity is needed. In both dairy cattle and women, a change in body temperature has been shown to occur immediately prior to ovulation. Research on horses has been limited, although one study reported no useable relationship between body temperature and ovulation in mares (Ammons, 1989). The current study utilized thirty-eight mature cycling American Quarter Horse mares, and was conducted from March-August 2004. Each mare was implanted in the nuchal ligament with a microchip that can be used for identification purposes, but is also capable of reporting body temperature. Once an ovulatory follicle (>35mm) was detected using ultrasonography and the mare was exhibiting signs of estrus, the mare's follicle size and temperature were recorded approximately every six hours until ovulation. Not only was the temperature collected using the microchips, but the corresponding rectal temperature was also recorded using a digital thermometer. A significant effect (p<0.05) on body temperature was noted in relation to the presence or absence of an ovulatory follicle (>35mm) under different circumstances. When evaluating the rectal temperatures, no significant difference was found in temperature in relation to the presence or absence of a follicle. However, in the temperatures obtained using the microchip, temperature was higher (p<0.05) with the presence of a follicle of greater than 35mm. This may be due to the extreme sensitivity of the microchip implant and its ability to more closely reflect minute changes in body temperature.